July 15 Session
Registration opens July 1.The selected study examines how small molecules bind and inhibit the main protease of SARS-CoV-2. Our presenter and panelists, with their diverse expertise, will lead an in-depth discussion of the findings and explore the impacts of the structure of antivirals to inhibit SARS-CoV-2 proteins.
Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against Mpro and cathepsin L.
Authors: Michael Dominic Sacco, Chunlong Ma, Panagiotis Lagarias, Ang Gao, Julia Alma Townsend, Xiangzhi Meng, Peter Dube, Xiujun Zhang, Yanmei Hu, Naoya Kitamura, Brett Hurst, Bart Tarbet, Michael Thomas Marty, Antonios Kolocouris, Yan Xiang, Yu Chen and Jun Wang.
Science Advances (2020)
DOI: 10.1126/sciadv.abe0751
Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).
Moderator
Presenter
Joyce Jose, Ph.D.
Huck Institutes of the Life Science, The Pennsylvania State University
Discussion Panel
Arnab Chatterjee, Ph.D.
Calibr at Scripps Research
Matthew D. Hall, Ph.D.
National Center for Advancing Translational Sciences, National Institutes of Health
Next Session
Aug. 19, 2021, 2 p.m. ET (registration will open Aug. 1)
Missed a past session?
Recordings are available free to ASM members.
View the Journal Club Archives